Package 78206-147-01
Brand: ontruzant
Generic: trastuzumabPackage Facts
Identity
Package NDC
78206-147-01
Digits Only
7820614701
Product NDC
78206-147
Description
1 VIAL, SINGLE-DOSE in 1 CARTON (78206-147-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (78206-147-99)
Marketing
Marketing Status
Brand
ontruzant
Generic
trastuzumab
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "a1dc858f-6aa7-4a25-a7bd-15a05aa4115c", "openfda": {"nui": ["N0000175661", "N0000020008"], "upc": ["0378206147011"], "unii": ["P188ANX8CK"], "rxcui": ["2289227", "2289232", "2289234", "2289237"], "spl_set_id": ["ce2a2492-85e3-4b0a-872a-047f44e4203d"], "pharm_class_epc": ["HER2/neu Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER2/Neu/cerbB2 Antagonists [MoA]"], "manufacturer_name": ["Organon LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (78206-147-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (78206-147-99)", "package_ndc": "78206-147-01", "marketing_start_date": "20210601"}], "brand_name": "Ontruzant", "product_id": "78206-147_a1dc858f-6aa7-4a25-a7bd-15a05aa4115c", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["HER2/Neu/cerbB2 Antagonists [MoA]", "HER2/neu Receptor Antagonist [EPC]"], "product_ndc": "78206-147", "generic_name": "trastuzumab", "labeler_name": "Organon LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ontruzant", "active_ingredients": [{"name": "TRASTUZUMAB", "strength": "150 mg/1"}], "application_number": "BLA761100", "marketing_category": "BLA", "marketing_start_date": "20210601", "listing_expiration_date": "20261231"}